Literature DB >> 6974732

Characterization of the binding of purified human C1q to heart mitochondrial membranes.

S B Storrs, W P Kolb, R N Pinckard, M S Olson.   

Abstract

The binding of purified, radioiodinated human C1q to baboon heart mitochondrial membranes was investigated. The interaction of C1q with heart mitochondrial membranes was shown to be readily saturable, specific for C1q, and reversible upon addition of unlabeled C1q or increasing salt concentrations. Scatchard plots of the binding data were biphasic and yielded association constants on the order of 1 X 10(10) and 1 X 10(9) M-1 and binding capacities of approximately 0.16 and 0.24 nmol of C1q/mg of mitochondrial protein. The binding of C1q to isolated cardiac-derived mitochondrial membranes is implicated in the antibody-independent activation of the classical complement pathway by cellular membranes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6974732

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  The mitochondrial protein C1qbp promotes cell proliferation, migration and resistance to cell death.

Authors:  Allison M McGee; Diana L Douglas; Yayun Liang; Salman M Hyder; Christopher P Baines
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

2.  Fc-mediated binding of IgG to vimentin-type intermediate filaments in vascular endothelial cells.

Authors:  G K Hansson; G A Starkebaum; E P Benditt; S M Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

3.  Decay-accelerating factor in the cardiomyocytes of normal individuals and patients with myocardial infarction.

Authors:  A Zimmermann; H Gerber; V Nussenzweig; H Isliker
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

4.  Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer.

Authors:  Olivia Jane Scully; Yingnan Yu; Agus Salim; Aye Aye Thike; George Wai-Cheong Yip; Gyeong Hun Baeg; Puay-Hoon Tan; Ken Matsumoto; Boon Huat Bay
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-07

Review 5.  The first component of human complement (C1): activation and control.

Authors:  R J Ziccardi
Journal:  Springer Semin Immunopathol       Date:  1983

6.  Quantitative measurement of SC5b-9 and C5b-9(m) in infarcted areas of human myocardium.

Authors:  F Hugo; T Hamdoch; D Mathey; H Schäfer; S Bhakdi
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

Review 7.  Myocardial ischemia and reperfusion: the role of oxygen radicals in tissue injury.

Authors:  S W Werns; B R Lucchesi
Journal:  Cardiovasc Drugs Ther       Date:  1989-01       Impact factor: 3.727

8.  Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4.

Authors:  B Aubert; S Chesne; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1985-12-01       Impact factor: 3.857

9.  Quantitative proteomic profiling of hepatocellular carcinoma at different serum alpha-fetoprotein level.

Authors:  Xuyong Wei; Renyi Su; Mengfan Yang; Binhua Pan; Jun Lu; Hanchao Lin; Wenzhi Shu; Rui Wang; Xiao Xu
Journal:  Transl Oncol       Date:  2022-04-14       Impact factor: 4.803

10.  Biological effects of short-term, high-concentration exposure to methyl isocyanate. VI. In vitro and in vivo complement activation studies.

Authors:  W P Kolb; J R Savary; C M Troup; D E Dodd; J D Tamerius
Journal:  Environ Health Perspect       Date:  1987-06       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.